On Sept. 9, 2021, the National Institutes of Health (NIH) announced that it was providing approximately $185 million…
On Sept. 8, 2021, AIM ImmunoTech announced that is had submitted a Pre-Investigational New Drug application (Pre-IND) to…
On Sept. 8, 2021, Novavax announced enrollment of the first participants in a Phase 1/2 study to evaluate…
On Sept. 8, 2021, National Resilience announced an agreement to manufacture mRNA for the Moderna COVID-19 vaccine. Under…
On Sept. 8, 2021, Bio-Techne and Carterra announced a clinical research collaboration studying COVID-19 variants. To assess immune…
On Sept. 7, 2021, Takeda Pharmaceutical announced the Government of Japan’s Ministry of Health, Labour and Welfare purchase…
On Sept. 6, 2021, Pfizer and BioNTech announced that they had submitted a variation to the European Medicines…
On Sept. 6, 2021, a genomic analysis of lung cancer in people with no history of smoking has…
On Sept. 3, 2021, the Centers for Disease Control and Prevention (CDC) awarded more than $116 million in…
On Sept. 3, 2021, Moderna announced that it had submitted for a conditional marketing approval (CMA) with the…
On Sept. 2, 2021, Thermo Fisher Scientific announced a $192.5 million contract award from the U.S. Department of…
On Sept. 2 , 2021, an Oxford University Study showed that the most recent common ancestor of these…
On Sept. 1, 2021, the World Health Organization inaugurated the new WHO Hub for Pandemic and Epidemic Intelligence…
On Sept. 1, 2021, Rigel Pharma announced the publication of results from a Phase 2 clinical trial evaluating…
On Sept. 1, 2021, Moderna announced it had initiated its submission to the U.S. Food and Drug Administration…
On Sept. 1, 2021, Quidel announced it will make Quidelﾒs non-prescription QuickVueﾮ At-Home OTC COVID-19 Test available to…
On Aug. 31, 2021, RELIEF THERAPEUTICS reported that the parent company of its U.S. collaboration partner, NRx Pharmaceuticals…
On Aug. 31, 2021, Novartis announced a commercial agreement with the NHS in England as part of a…
On Aug. 31, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
On Aug. 31, 2021, SK bioscience and GlaxoSmithKline announced the initiation of a Phase 3 clinical study of…
On Aug. 30, 2021, after 30 years of steady progress, National Institute of Allergy and Infectious Diseases (NIAID)…
On Aug. 30, 2021, AXIMﾮ Biotechnologies announced that the Companyﾒs manufacturing partner Empowered Diagnostics had filed an amended…
On Aug. 30, 2021, CureVac announced the publication of its pivotal Phase 2b/3 (HERALD study) primary data of…
On Aug. 30, 2021, the United Nations announced the global phase-out of leaded fuel, a milestone for multilateralism,…
On Aug. 30, 2021, OPKO announced completion of enrollment in its Phase 2 trial with RAYALDEEﾮ as a…
On Aug. 30, 2021, Oragenics announced that the stabilized pre-fusion spike protein trimer produced by its Canadian collaborator…
On Aug. 30, 2021, the Mayo Clinic reported that in an observational study the combination of casirivimab and…
On Aug. 27, 2021, researchers at University of British Columbia’s (UBC) faculty of medicine and BC Cancer Research…
On Aug. 27, 2021, The National Institutes of Health announced that it had begun a clinical trial to…
On Aug. 27, 2021, National Aeronautics and Space Administration (NASA) Space station astronauts successfully demonstrated DNA repair in…